patient must have recover from the toxic effect of prior therapy 2 week from any investigational agent 4 week from prior cytotoxic therapy two week from vincristine 6 week from nitrosoureas 3 week from procarbazine administration and 1 week for non-cytotoxic agent e.g. interferon thalidomide cis-retinoic acid etc radiosensitizer do not count any question relate to the definition of non-cytotoxic agent should be direct to the study chair 